For example, HDAC3 has been shown to promote expression of the lung cancer lineage transcription factor NKX2-1, which drives progression and therapeutic resistance in non-small-cell lung cancer (NSCLC) [13]. Here, NKX2-1 is linked to non-small cell lung carcinoma.